ETFs Alcon Inc.

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:00 2026-06-12 am EDT			5-day change	1st Jan Change
53.16 ^CHF	+0.87%		+0.08%	-15.99%

May. 28	Swiss Equities Slip as Renewed Middle East Tensions Rattle Markets	MT
May. 25	Baptista Research Upgrades Alcon to Buy Rating	MT

ETFs positioned on Alcon Inc.

Name	YTD change	Weight	AuM
LYXOR DJ SWITZERLAND TITANS 30 (DR) UCITS ETF- CHF	-.--%	3.96%	121 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+5.61%	1.24%	27 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	+7.24%	0.13%	33,076 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	+9.89%	0.07%	426 M€
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	+4.48%	0.02%	37 M€
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR	+1.99%	0.01%	15 M€
CI MARRET ALTERNATIVE ABSOLUTE RETURN BOND ETF - CAD	0.00%	-0%	12 M€

1 2

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).

Employees

25,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

Earnings release - Q2 2026

More about the company